Similar articles

• Therapy of gram-negative sepsis in man with anti-endotoxin antibodies: a review.

  Wortel CH, Ziegler EJ, van Deventer SJ. Wortel CH, et al. Prog Clin Biol Res. 1991;367:161-78. Prog Clin Biol Res. 1991. PMID: 1924425 Review. No abstract available.
• Therapies for sepsis. Emerging therapies for sepsis and septic shock.

  Abraham E. Abraham E. West J Med. 1997 Mar;166(3):195-200. West J Med. 1997. PMID: 9143195 Free PMC article. No abstract available.
• Bayesian evaluation of group sequential clinical trial designs.

  Emerson SS, Kittelson JM, Gillen DL. Emerson SS, et al. Stat Med. 2007 Mar 30;26(7):1431-49. doi: 10.1002/sim.2640. Stat Med. 2007. PMID: 17066402
• New strategies in nonantibiotic treatment of gram-negative sepsis.

  Cohn J, Bone RC. Cohn J, et al. Cleve Clin J Med. 1992 Nov-Dec;59(6):608-15. doi: 10.3949/ccjm.59.6.608. Cleve Clin J Med. 1992. PMID: 1424072 Review.
• [Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis].

  Candel FJ, Martínez-Sagasti F, Borges M, Maseda E, Herrera-Gutiérrez M, Garnacho-Montero J, Maynar FJ, Zaragoza R, Mensa J, Azanza JR. Candel FJ, et al. Rev Esp Quimioter. 2010 Sep;23(3):115-21. Rev Esp Quimioter. 2010. PMID: 20844841 Review. Spanish.